Cargando…
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity
The immune checkpoints associated with the CTLA-4 and PD-1 pathways are critical modulators of immune activation. These pathways dampen the immune response by providing brakes on activated T cells, thereby ensuring more uniform and controlled immune reactions and avoiding immune hyper-responsiveness...
Autores principales: | Shannon, Vickie R., Anderson, Ronald, Blidner, Ada, Choi, Jennifer, Cooksley, Tim, Dougan, Michael, Glezerman, Ilya, Ginex, Pamela, Girotra, Monica, Gupta, Dipti, Johnson, Douglas B., Suarez-Almazor, Maria E., Rapoport, Bernardo L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471521/ https://www.ncbi.nlm.nih.gov/pubmed/32880733 http://dx.doi.org/10.1007/s00520-020-05708-2 |
Ejemplares similares
-
Pulmonary Toxicities Associated With the Use of Immune Checkpoint Inhibitors: An Update From the Immuno-Oncology Subgroup of the Neutropenia, Infection & Myelosuppression Study Group of the Multinational Association for Supportive Care in Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2021) -
Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper
por: Cooksley, Tim, et al.
Publicado: (2020) -
A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative
por: Leon Rapoport, Bernardo, et al.
Publicado: (2023) -
Frontiers in Pharmacology: Review Manuscript Targeting of the Neutrophil as an Adjunctive Strategy in Non-Small Cell Lung Cancer
por: Anderson, Ronald, et al.
Publicado: (2021) -
Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/guidance on the use of clinically assisted nutrition in patients with advanced cancer
por: Alderman, Bryony, et al.
Publicado: (2021)